Slowing the ramp to the label cadence (2.5 mg start, 2.5 mg steps, four-week holds) dropped that to mid-single digits at every maintenance dose, at no cost to the 12-week result, and the dedicated slow-titration trial reached placebo range. Reaching 15 mg is not the problem
if you develop symptoms like hives, difficulty breathing, chest tightness, or severe dizziness after an injection, seek medical attention, as those could indicate an allergic reaction (which is extremely uncommon)
Stable formulation extends shelf life, supporting long-term research use
What alternative treatment options do I have
But since your injection bypasses the gut, that particular interaction is not an issue for the injection itself
Specifically, it seemed that BPC-157 could regulate the phosphorylation level of extracellular signal-regulated kinases 1 and 2 (ERK1/2)